Bioburden and Endotoxin Assessment

Comprehensive bioburden and endotoxin assessment services supporting microbiological control in medical device and pharmaceutical manufacturing.

Bioburden and Endotoxin Assessment

Comprehensive bioburden and endotoxin assessment services supporting microbiological control in medical device and pharmaceutical manufacturing.

Bioburden Assessment

Bioburden assessment measures the number of viable microorganisms present on a product, component, or raw material prior to sterilisation. In medical device and pharmaceutical manufacturing, understanding the level of microbial contamination is essential for establishing and maintaining effective sterilisation processes. Bioburden testing provides valuable data that supports product safety and microbiological quality control.

Routine bioburden assessment also helps manufacturers monitor their production environment and manufacturing processes. By evaluating microbial levels over time, organisations can identify trends, detect changes in contamination levels, and verify that manufacturing controls remain effective throughout the product lifecycle.

Comprehensive bioburden and endotoxin assessment services supporting microbiological control in medical device and pharmaceutical manufacturing.
Comprehensive bioburden and endotoxin assessment services supporting microbiological control in medical device and pharmaceutical manufacturing.

Endotoxin assessment focuses on detecting bacterial endotoxins that may remain on a product even after microorganisms are no longer viable. Endotoxins are components of the cell wall of certain bacteria and can cause adverse reactions if introduced into the body. Monitoring endotoxin levels is therefore an important safety requirement for many sterile medical devices and pharmaceutical products.

Endotoxin testing is commonly performed using the Limulus Amebocyte Lysate method, which is capable of detecting very low levels of endotoxin contamination. Regular endotoxin assessment helps confirm that manufacturing processes, materials, and sterilisation procedures effectively control endotoxin levels within acceptable safety limits.

Endotoxin Assessment

Bioburden and Endotoxin Testing at CLS

CLS provides bioburden and endotoxin assessment services designed to support manufacturers in the medical device and pharmaceutical industries. Testing is performed using validated microbiological methods that deliver accurate and reliable results while meeting applicable regulatory and industry standards.

The CLS microbiology laboratory works with clients to develop testing programmes that align with product requirements, sterilisation validation activities, and regulatory expectations. Through dependable bioburden and endotoxin assessment, CLS helps manufacturers maintain microbiological control, support product safety, and ensure compliance with regulatory requirements.

Trusted by leading names

We are your partner in medical device and Pharmaceutical testing and compliance.

Speak to our QC specialists today.